![Jun Yoon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jun Yoon
Directeur Financier/CFO chez STRUCTURE THERAPEUTICS INC.
Fortune : 30 M $ au 31/05/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Raymond Stevens | M | 60 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 ans |
Sharon Tetlow | F | 64 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 2 ans |
Jessica Lifton | F | - |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | - |
Karen S. Wright | F | 69 | 7 ans | |
Ramy Farid | M | 59 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 ans |
Chen-Ming Yu | M | 50 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | - |
Eric Dobmeier | M | 55 | 2 ans | |
Daniel Welch | M | 66 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 2 ans |
Ted Love | M | 65 | 1 ans | |
Xi Chen Lin | M | 50 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | 5 ans |
Joanne Waldstreicher | M | 64 | 2 ans | |
Ying Li Ma | M | 50 | 2 ans | |
William Reed | M | - |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 11 ans |
Mark Bach | M | 67 | 3 ans | |
Cui Ping Gu | M | 44 |
Shanghai ShouTi Biotechnology Co., Ltd.
![]() Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | - |
Lani Ibarra | F | - | - | |
Tony Peng | M | - | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Mark Bagnall | M | 67 | 4 ans | |
John Randolph Larson | M | 77 | - | |
James Stewart | M | - | 4 ans | |
James Gordon Stewart | M | 71 | 3 ans | |
Lowell E. Sears | M | 73 |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 5 ans |
Margaret Dillon | M | - |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | - |
David T. Howard | M | 74 | - | |
Adeoye Olukotun | M | 79 | 4 ans | |
Sean Givens | M | - |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | - |
Raymond Tabibiazar | M | 53 | 2 ans | |
Leslie Tari | M | 57 |
Syrrx, Inc.
![]() Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 ans |
Sean Healy | M | - |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | - |
Edward Chiang | M | - | 5 ans | |
Robert Tressler | M | - |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | - |
Jun S. Yoon | M | - | 6 ans | |
Tilmann M. Brotz | M | - | - | |
Fred Craves | M | 78 | 7 ans | |
Rebecca Taub | M | 71 | 3 ans | |
Brendan P. Rae | M | - | 5 ans | |
Richard L. Anderson | M | 84 | 2 ans | |
Michael Perry | M | 64 | 4 ans | |
James C. Gilstrap | M | 88 | - | |
George B. Rathmann | M | - |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | - |
Gisela Schwab | M | 67 |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 9 ans |
Rodney Young | M | 61 |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 4 ans |
Norman L. Halleen | M | 70 |
Syrrx, Inc.
![]() Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Syrrx, Inc. used to develops drugs. Its focus was on creating novel therapies for cancer, metabolic diseases and inflammation. The company was the technology leader in the field of structural proteomics, the process of generating protein structures from genetic information. It was headquartered in San Diego, CA | 2 ans |
Kristen Hege | M | 60 |
Cellerant Therapeutics, Inc.
![]() Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 1 ans |
Melita Jung | F | 47 | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 44 | 97,78% |
Chine | 8 | 17,78% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations